FibroGen, Inc. (0IL8.L)
USD 0.36
(3.62%)
USD 0.36
(3.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -315.02 Million | -145.93 Million | -82.23 Million | 81.6 Million | -78.7 Million | -76.14 Million |
| Net Income | -284.23 Million | -293.65 Million | -290.02 Million | -189.29 Million | -76.97 Million | -86.42 Million |
| Depreciation & Amortization | 9.93 Million | 10.6 Million | 14.8 Million | 22.04 Million | 21.45 Million | 6.56 Million |
| Deferred income taxes | 13.77 Million | - | 1.73 Million | 1.29 Million | -3.7 Million | - |
| Stock-based compensation | 50.76 Million | 65.6 Million | 71.16 Million | 72.72 Million | 66.26 Million | 52.14 Million |
| Change in working capital | -119.68 Million | 70.43 Million | 60.08 Million | 174.63 Million | -85.65 Million | -48.39 Million |
| Other non-cash items | 14.42 Million | 1.08 Million | 60 Million | 202 Thousand | -88 Thousand | -30 Thousand |
| Investing Cash Flow | 153.65 Million | 89.11 Million | -426.97 Million | 452.48 Million | 120.01 Million | -522.12 Million |
| Investments in PPE | -2.51 Million | -38.74 Million | -30.18 Million | -3.99 Million | -5.76 Million | -8.02 Million |
| Acquisitions | 656 Thousand | 6000.00 | 25 Million | -3.89 Million | 7000.00 | 184 Thousand |
| Investment purchases | -251.83 Million | -164.02 Million | -484.14 Million | -8.19 Million | -411.29 Million | -576.88 Million |
| Sales/Maturities of investments | 407.35 Million | 291.87 Million | 87.35 Million | 468.56 Million | 537.07 Million | 62.59 Million |
| Other Investing Activities | 155.52 Million | -35 Million | -25 Million | 456.48 Million | 125.78 Million | 184 Thousand |
| Financing Cash Flow | 122.74 Million | 46.77 Million | -563 Thousand | 13.34 Million | -4.3 Million | 13.87 Million |
| Debt repayment | -71.18 Million | -538 Thousand | -5.89 Million | -13.02 Million | -12.32 Million | -409 Thousand |
| Dividends payments | -2.25 Million | - | - | - | - | - |
| Common Stock Repurchased | 1.91 Million | -5.16 Million | -7.37 Million | -11.46 Million | -12.75 Million | -15.61 Million |
| Common Stock Issuance | 52.13 Million | 4.18 Million | 12.7 Million | 37.82 Million | 20.77 Million | 29.84 Million |
| Other Financing Activities | 142.13 Million | 53.46 Million | 7.37 Million | 11.46 Million | 12.75 Million | -15.56 Million |
| Accounts receivables | 3.43 Million | 765 Thousand | 25.18 Million | -11.97 Million | 35.22 Million | -55.23 Million |
| Accounts payables | -15.51 Million | 5.9 Million | 805 Thousand | 17.73 Million | -3.05 Million | 3.63 Million |
| Inventory | -1.69 Million | -10.99 Million | -14.15 Million | -9.17 Million | -6.88 Million | 8.23 Million |
| Other working capital | -105.91 Million | 74.75 Million | 48.25 Million | 178.04 Million | -110.95 Million | -5.03 Million |
| Cash at beginning of period | 155.7 Million | 171.22 Million | 678.39 Million | 126.26 Million | 89.25 Million | 673.65 Million |
| Cash at end of period | 113.68 Million | 155.7 Million | 171.22 Million | 678.39 Million | 126.26 Million | 89.25 Million |
| Capital Expenditure | -2.51 Million | -38.74 Million | -30.18 Million | -3.99 Million | -5.76 Million | -8.02 Million |
| Effect of forex changes on cash | -3.39 Million | -5.48 Million | 2.59 Million | 4.69 Million | -5000.00 | -8000.00 |
| Net cash flow / Change in cash | -42.01 Million | -15.52 Million | -507.17 Million | 552.12 Million | 37 Million | -584.4 Million |
| Free Cash Flow | -317.54 Million | -184.67 Million | -112.41 Million | 77.6 Million | -84.46 Million | -84.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.54 Million | -32.93 Million | -56.23 Million | -284.23 Million | -63.61 Million | -87.68 Million |
| Depreciation & Amortization | 781 Thousand | 820 Thousand | 1.87 Million | 9.93 Million | 2.37 Million | 2.71 Million |
| Deferred income taxes | - | - | 1.93 Million | 13.77 Million | -261 Thousand | -1.67 Million |
| Stock-based compensation | 8.58 Million | 8.76 Million | 9.29 Million | 50.76 Million | 9.47 Million | 15.88 Million |
| Change in working capital | -32.43 Million | -34.05 Million | 26.66 Million | -119.68 Million | -34.57 Million | -65.77 Million |
| Other non-cash items | -29.15 Million | 33 Million | -1.85 Million | 14.42 Million | 2.05 Million | 25.96 Million |
| Investing Cash Flow | 72.23 Million | 51.27 Million | 10.24 Million | 153.65 Million | 54.21 Million | -14.28 Million |
| Investments in PPE | -14 Thousand | -29 Thousand | -251 Thousand | -2.51 Million | -684 Thousand | -993 Thousand |
| Acquisitions | 3000.00 | - | 158.31 Million | 656 Thousand | -54.9 Million | 656 Thousand |
| Investment purchases | - | -8.62 Million | -94.62 Million | -251.83 Million | -52.66 Million | -102.07 Million |
| Sales/Maturities of investments | 72.25 Million | 59.93 Million | 105.11 Million | 407.35 Million | 107.56 Million | 88.12 Million |
| Other Investing Activities | 72.25 Million | 51.3 Million | -158.31 Million | 155.52 Million | 54.9 Million | -13.94 Million |
| Financing Cash Flow | 32 Thousand | -165 Thousand | -246 Thousand | 122.74 Million | -22 Thousand | 91.53 Million |
| Debt repayment | -8000.00 | -12 Thousand | -20 Thousand | -71.18 Million | -22 Thousand | -236 Thousand |
| Dividends payments | - | - | -2.25 Million | -2.25 Million | - | - |
| Common Stock Repurchased | -76 Thousand | -153 Thousand | 2.22 Million | 1.91 Million | - | - |
| Common Stock Issuance | 116 Thousand | - | 45 Thousand | 52.13 Million | - | 17.65 Million |
| Other Financing Activities | -76 Thousand | -153 Thousand | -237 Thousand | 142.13 Million | -22 Thousand | 74.11 Million |
| Accounts receivables | 30.64 Million | -24.68 Million | 19.71 Million | 3.43 Million | -6.27 Million | -8.7 Million |
| Accounts payables | 5.61 Million | -13.58 Million | -1.45 Million | -15.51 Million | 6.72 Million | -61.25 Million |
| Inventory | 1.79 Million | 13.78 Million | -176 Thousand | -1.69 Million | 432 Thousand | -11 Thousand |
| Other working capital | -70.48 Million | -9.56 Million | 8.57 Million | -105.91 Million | -35.45 Million | 4.2 Million |
| Cash at beginning of period | 105.73 Million | 113.68 Million | 120.91 Million | 155.7 Million | 152.58 Million | 188.55 Million |
| Cash at end of period | 140.71 Million | 105.73 Million | 113.68 Million | 113.68 Million | 120.91 Million | 152.58 Million |
| Capital Expenditure | -14 Thousand | -29 Thousand | -251 Thousand | -2.51 Million | -684 Thousand | -993 Thousand |
| Effect of forex changes on cash | 2.57 Million | 223 Thousand | 1.09 Million | -3.39 Million | -1.32 Million | -2.64 Million |
| Net cash flow / Change in cash | 34.98 Million | -7.95 Million | -7.22 Million | -42.01 Million | -31.67 Million | -35.96 Million |
| Free Cash Flow | -39.88 Million | -59.31 Million | -18.57 Million | -317.54 Million | -85.22 Million | -111.56 Million |
EOL
600026
CMB
AGM
CMCM
SENR